News from can-fite biopharma A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Sep 17, 2014, 15:02 ET

Can-Fite Files June 30, 2014 Interim Financial Statements

 Can-Fite BioPharma  Ltd. (TASE:CFBI), (NYSE MKT:CANF),  a biotechnology company with a pipeline of proprietary small molecule...

Sep 17, 2014, 07:00 ET

Can Fite's Drug CF101 is Presented in Scientific Journal as One of Four Small Molecule Drugs for the Treatment of Psoriasis

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that...

Sep 05, 2014, 07:00 ET

Can-Fite Issued Japanese Patent for CF102 in the Treatment of Liver Regeneration and Function Following Surgery

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that...

Sep 03, 2014, 07:00 ET

Can-Fite to Present at Rodman & Renshaw Global Investment Conference in New York City on September 9, 2014

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address...

Sep 02, 2014, 07:00 ET

Can-Fite Reports First Six Months 2014 Results

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that...

Aug 06, 2014, 07:00 ET

New Data Shows High Efficacy for Can-Fite's CF101 in Rheumatoid Arthritis and Psoriasis Patients

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address...

Jul 21, 2014, 07:00 ET

Can-Fite CEO to Deliver Scientific Presentation and Serve on Expert Panel at Purines 2014 in Bonn, Germany on July 23-27, 2014

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that...

Jul 10, 2014, 07:00 ET

Can-Fite's CF102 Approved for Compassionate Use in Israel for Liver Cancer Patient

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that...

Jun 19, 2014, 07:00 ET

Can-Fite to Exhibit at Bio International Convention in San Diego on June 23 - 26, 2014

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address...

Jun 17, 2014, 07:00 ET

Can-Fite Completes Patient Enrollment in its Phase II/III Psoriasis Trial; Final Results are expected in Q1 2015

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that...

Jun 10, 2014, 07:00 ET

Can-Fite to Participate in Newport Coast Securities Conference in New York & ROTH Conference in London

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address...

Jun 09, 2014, 07:00 ET

Can-Fite Subsidiary OphthaliX Provides an Update on its Clinical Developments and Strategic Plans

Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address...

Jun 02, 2014, 07:00 ET

Can-Fite Announces that the US FDA has Agreed with its Phase II Liver Cancer Protocol

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address...

May 30, 2014, 16:32 ET

Can-Fite Announces 2014 Annual General Meeting

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address...

May 29, 2014, 07:00 ET

Can-Fite Reports First Quarter 2014 Results

Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address...

May 15, 2014, 07:00 ET

Can-Fite to Exhibit at MIXiii Biomed Israel Innovation Conference

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that...

May 07, 2014, 11:41 ET

Can-Fite Receives Patent in European Union for Treatment of Liver Function Following Surgery

Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address...

Apr 29, 2014, 07:00 ET

Can-Fite Submits Protocol to U.S. FDA for Phase II Liver Cancer Study

Can-Fite BioPharma Ltd. (NYSE MKT:CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address...

Apr 21, 2014, 07:00 ET

Can-Fite Initiates the Development of an A3AR Biomarker Test Kit to Predict Patients' Response to Company's Drugs

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address...

Mar 31, 2014, 14:28 ET

Can-Fite Files 2013 Annual Report on Form 20-F

 Can-Fite BioPharma Ltd. (TASE: CFBI), (NYSE MKT: CANF), a biotechnology company with a pipeline of proprietary small molecule...